Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8225663 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 6 Pages |
Abstract
In patients with high-grade prostate cancer, treatment with brachytherapy is associated with reduced PCSM compared with EBRT alone. Our results suggest that brachytherapy should be investigated as a component of definitive treatment strategies for patients with high-risk prostate cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Xinglei M.D., Scott W. Ph.D., Mark V. M.D., Adam P. M.D., Ph.D., Timothy N. M.D.,